Treatment of acute supratentorial ischemic stroke with abciximab is safe and may result in early neurological improvement. A preliminary report.
Mitsias
Panayiotis D
PD
Department of Neurology, Henry Ford Health Sciences Center, Detroit, Mich. 48202, USA. mitsias@neuro.hfh.edu
Lu
Mei
M
Morris
Dan
D
Silver
Brian
B
Lewandowski
Christopher
C
Papamitsakis
Nikolaos I
NI
Khaligi
Mohammed M
MM
Ebadian
Hassan B
HB
Zhao
Qingming
Q
Soltanian-Zadeh
Hamid
H
Daley
Sheila
S
Hearshen
David
D
Ewing
James R
JR
Patel
Suresh C
SC
Chopp
Michael
M
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D009420:Nervous System / Q000187:drug effects / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012720:Severity of Illness Index; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab